Embedding DEI into Our Purpose
Building on our reputation as a leader in diversity, equity, and inclusion (DEI), we updated our DEI strategy in 2021 to embed these principles into our workplace and further advance one of our five Bold Moves, unleash the power of our people.
Our updated strategy embraces the vision to be a best-in-class organization that embeds DEI in our workplace and into our purpose of delivering breakthroughs that change patients’ lives, and includes a new governance model. By having a clear overarching DEI vision, we’re able to outline distinct DEI roles and accountabilities, align our therapeutic areas and divisions with our vision, and assess our progress against measurable outcomes. As our Chief Diversity, Equity and Inclusion Officer Ramcess Jean-Louis said, “We approach DEI with the same Pfizer discipline applied to everything else we do – what gets measured, gets improved. Pfizer’s DEI strategy is built around tangible efforts that can be measured against three key stakeholder pillars.”
These three pillars support our core value of Equity, ensuring every person is seen, heard, and cared for. The pillars include building a more inclusive colleague experience, advancing equitable health outcomes, and transforming society with external DEI partnerships – creating a strong foundation from which to develop an inclusive workplace for all.
From supplier diversity to equitable accessibility planning for product launches, we considered all aspects of our business and identified ways to embed DEI, remove barriers, and build our inclusive culture.
Our new strategy came to life in 2021 through our first global safe space listening session and launch of our Breakthrough Fellowship Program. The global safe space listening session was in response to the Afghanistan withdrawal and offered colleagues, especially those who identify as refugees or veterans, an opportunity to share their feelings around the news. Safe space listening conversations will continue to be planned based on world events.
Understanding that minority communities are underrepresented in leadership across corporate America, the Breakthrough Fellowship Program is a nine-year commitment to increase minority representation at Pfizer. It’s a first-of-its-kind fellowship program focused on advancing undergraduate students and fellows of Black/African American, Latino Community/Hispanic and Native American descent with the goal of engaging 100 Fellows by 2025.
Learn more about our diversity and belonging efforts, inclusive research, and partnerships in the Social section of this year’s ESG Report.